Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients
- Conditions
- Age-Related Macular Degeneration
- Interventions
- Other: National Eye Institute Visual Function Questionnaire
- Registration Number
- NCT05427994
- Lead Sponsor
- Asfendiyarov Kazakh National Medical University
- Brief Summary
The aim of this study is to evaluate the quality of life of AMD patients related to vision using the short version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25), patients' social support, and their relationship with demographic and clinical variables.
- Detailed Description
Background and study aims. Age-related macular degeneration (AMD) is the most prevalent chronic progressive ocular disease. It has been shown in several studies that AMD affects the quality of life of patients. The aim of this study is to evaluate the quality of life of AMD patients related to vision using the short version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25), patients' social support, and their relationship with demographic and clinical variables.
Who can participate? Patients with AMD, who wish to participate, will be recruited. Patients will be recruited from three locations of the Kazakh Scientific - Research Institute of Eye Diseases in Almaty, Nur-Sultan and Shymkent.
What does the study involve? The study involves collecting demographic data of the participants, collecting baseline visual testing data from medical records, filling out of the NEI-VFQ-25, and answering two yes/no questions related to the social support and reliability of social support.
What are possible benefits and risks of participating? Assessment of quality of life and social support of the AMD patients is a first step of developing targeted psycho-social support programs for AMD patients.
Where is the study run from? Patients will be recruited from three locations of the Kazakh Scientific - Research Institute of Eye Diseases in Almaty, Nur-Sultan and Shymkent.
When is the study starting and how long it is expected to run for? Start date 03/02/2020. End date 27/08/2022.
Who is funding the study? No funding for this study. Who is the main contact? Principal investigator: Inara Ismailova; +380 73 200 0688; i.ismayilova@gmail.com
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 458
- age-related macular degeneration; ability to speak and understand Russian and/or Kazakh language; willingness to participate
- Presence of glaucoma, cataracts of grade 2 or more according to the Lens Opacities Classification System (LOCS) III, and the presence of corneal opacities or any other retinal diseases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with age-related macular degeneration National Eye Institute Visual Function Questionnaire Patients with age-related macular degeneration who fill out the quality of life questionnaire, and answer questions about social support and reliability of social support
- Primary Outcome Measures
Name Time Method Quality of life of AMD patients at the recruitment to the study Vision related Quality of life (QOL) of AMD patients related to vision assessed by NEI-VFQ-25 total score at the recruitment. NEI-VFQ-25 has 38 questions with multiple choice answers, each rated 0,25, 50, 75 or 100. The overall score is measured as a mean of all answers
- Secondary Outcome Measures
Name Time Method Social Support at the recruitment to the study Percentage of AMD patients with Social Support. Social Support of AMD patients at the recruitment assessed by answering a yes/no question.
Relationship between QOL and social support at the recruitment to the study Correlation between the overall quality of life of AMD patients and demographic, visual characteristics, and social support tested with multiple linear regression model. The Hosmer-Lemeshow goodness-of-fit test will be used to test the model's fit. All tests will be two-tailed with a significance level of 0.05.
Reliability of Social Support at the recruitment to the study Percentage of AMD patients with a reliable Social Support. Reliability of Social Support of AMD patients at the recruitment assessed by answering a yes/no question.
Trial Locations
- Locations (2)
Medical Centre Hospital of President'S Affairs Administration of the Republic of Kazakhstan
🇰🇿Astana, Kazakhstan
Kazakh Scientific - Research Institute of Eye Diseases
🇰🇿Almaty, Kazakhstan